Literature DB >> 29614657

Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease.

Dennis M Kamara1, Umesh Gangishetti2, Marla Gearing3, Monica Willis-Parker2, Liping Zhao4, William T Hu2, Lary C Walker2,5.   

Abstract

Cerebral amyloid angiopathy (CAA) of the Aβ type is variably present in the brains of patients with Alzheimer's disease (AD). CAA contributes to cognitive decline and increases the risk of lobar hemorrhage; because both AD-typical dementia and lobar hemorrhage are more common in African-Americans than in Caucasians, we postulated that African-Americans with AD might be particularly susceptible to CAA. To test this hypothesis, we analyzed CAA histopathologically in the large vessels and capillaries of autopsy-derived frontal, temporal, parietal, and occipital cortical samples from African-Americans (n = 18) and Caucasians (n = 19) with end-stage AD. In the combined cohort of 37 subjects, 22% of the subjects had severe CAA in large vessels, and 11% had severe CAA in capillaries. However, the prevalence and histopathologic characteristics of CAA were similar in the African-Americans and Caucasians. This conclusion was substantiated in an independent sample from the National Alzheimer's Coordinating Center database, in which the degree of CAA was comparable in 1,554 Caucasians and 68 African-Americans with end-stage AD. These findings support a growing consensus that the fundamental histopathologic features of AD are largely impartial to the race of the afflicted.

Entities:  

Keywords:  Aβ; aging; amyloid; cerebrovascular amyloidosis; dementia; ethnicity; race; tauopathy; vascular disease

Mesh:

Substances:

Year:  2018        PMID: 29614657      PMCID: PMC6103628          DOI: 10.3233/JAD-170954

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  75 in total

Review 1.  Deconstructing race and ethnicity: implications for measurement of health outcomes.

Authors:  Jennifer J Manly
Journal:  Med Care       Date:  2006-11       Impact factor: 2.983

2.  Challenges and Considerations Related to Studying Dementia in Blacks/African Americans.

Authors:  Eseosa T Ighodaro; Peter T Nelson; Walter A Kukull; Frederick A Schmitt; Erin L Abner; Allison Caban-Holt; Shoshana H Bardach; Derrick C Hord; Crystal M Glover; Gregory A Jicha; Linda J Van Eldik; Alexander X Byrd; Anita Fernander
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

3.  Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type.

Authors:  J Haan; J B Lanser; I Zijderveld; I G van der Does; R A Roos
Journal:  Arch Neurol       Date:  1990-09

Review 4.  Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.

Authors:  Peter T Nelson; Irina Alafuzoff; Eileen H Bigio; Constantin Bouras; Heiko Braak; Nigel J Cairns; Rudolph J Castellani; Barbara J Crain; Peter Davies; Kelly Del Tredici; Charles Duyckaerts; Matthew P Frosch; Vahram Haroutunian; Patrick R Hof; Christine M Hulette; Bradley T Hyman; Takeshi Iwatsubo; Kurt A Jellinger; Gregory A Jicha; Enikö Kövari; Walter A Kukull; James B Leverenz; Seth Love; Ian R Mackenzie; David M Mann; Eliezer Masliah; Ann C McKee; Thomas J Montine; John C Morris; Julie A Schneider; Joshua A Sonnen; Dietmar R Thal; John Q Trojanowski; Juan C Troncoso; Thomas Wisniewski; Randall L Woltjer; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2012-05       Impact factor: 3.685

Review 5.  Diversity and disparity in dementia: the impact of ethnoracial differences in Alzheimer disease.

Authors:  Alexander L Chin; Selamawit Negash; Roy Hamilton
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jul-Sep       Impact factor: 2.703

6.  Cerebral amyloid angiopathy in dementia and old age.

Authors:  M M Esiri; G K Wilcock
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-11       Impact factor: 10.154

7.  Degeneration of vascular muscle cells in cerebral amyloid angiopathy of Alzheimer disease.

Authors:  M Kawai; R N Kalaria; P Cras; S L Siedlak; M E Velasco; E R Shelton; H W Chan; B D Greenberg; G Perry
Journal:  Brain Res       Date:  1993-09-24       Impact factor: 3.252

Review 8.  The pathophysiology and clinical presentation of cerebral amyloid angiopathy.

Authors:  Eitan Auriel; Steven Mark Greenberg
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

9.  Dementia incidence and predictors in cerebral amyloid angiopathy patients without intracerebral hemorrhage.

Authors:  Li Xiong; Gregoire Boulouis; Andreas Charidimou; Duangnapa Roongpiboonsopit; Michael J Jessel; Marco Pasi; Yael D Reijmer; Panagiotis Fotiadis; Alison Ayres; Emily Merrill; Kristin Schwab; Deborah Blacker; M Edip Gurol; Steven M Greenberg; Anand Viswanathan
Journal:  J Cereb Blood Flow Metab       Date:  2017-03-20       Impact factor: 6.960

Review 10.  Cerebral amyloid angiopathy: emerging concepts.

Authors:  Masahito Yamada
Journal:  J Stroke       Date:  2015-01-30       Impact factor: 6.967

View more
  8 in total

1.  Alzheimer's disease: A clinical perspective and future nonhuman primate research opportunities.

Authors:  Rafi U Haque; Allan I Levey
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

2.  Aβ Plaques.

Authors:  Lary C Walker
Journal:  Free Neuropathol       Date:  2020-10-30

3.  Interleukin 9 alterations linked to alzheimer disease in african americans.

Authors:  Whitney Wharton; Alexander L Kollhoff; Umesh Gangishetti; Danielle D Verble; Samsara Upadhya; Henrik Zetterberg; Veena Kumar; Kelly D Watts; Andrea J Kippels; Marla Gearing; J Christina Howell; Monica W Parker; William T Hu
Journal:  Ann Neurol       Date:  2019-07-22       Impact factor: 10.422

4.  Neuropathology Studies of Dementia in US Persons other than Non-Hispanic Whites.

Authors:  My-le Nguyen; Emily Z Huie; Rachel A Whitmer; Kristen M George; Brittany N Dugger
Journal:  Free Neuropathol       Date:  2022-03-10

5.  Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.

Authors:  Mostafa J Khan; Heather Desaire; Oscar L Lopez; M Ilyas Kamboh; Renã A S Robinson
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.160

6.  Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort.

Authors:  Octavio A Santos; Otto Pedraza; John A Lucas; Ranjan Duara; Maria T Greig-Custo; Fadi S Hanna Al-Shaikh; Amanda M Liesinger; Kevin F Bieniek; Kelly M Hinkle; Elizabeth R Lesser; Julia E Crook; Minerva M Carrasquillo; Owen A Ross; Nilüfer Ertekin-Taner; Neill R Graff-Radford; Dennis W Dickson; Melissa E Murray
Journal:  Alzheimers Dement       Date:  2019-02-18       Impact factor: 21.566

7.  Stereological Changes in Microvascular Parameters in Hippocampus of a Transgenic Rat Model of Alzheimer's Disease.

Authors:  Yaroslav Kolinko; Lucie Marsalova; Stephanie Proskauer Pena; Milena Kralickova; Peter R Mouton
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

8.  Inclusion of African American/Black adults in a pilot brain proteomics study of Alzheimer's disease.

Authors:  Kaitlyn E Stepler; Emily R Mahoney; Julia Kofler; Timothy J Hohman; Oscar L Lopez; Renã A S Robinson
Journal:  Neurobiol Dis       Date:  2020-10-10       Impact factor: 5.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.